Top 5 Pharmaceutical Stocks for Your Watchlist Hosted by MarketBeat StaffOctober 4, 2023 ShareLink copied to clipboard. Play video for Top 5 Pharmaceutical Stocks for Your WatchlistDetailsGuestsIn this video, we explore the top pharmaceutical stocks to watch, including industry giants and promising hidden gems. We discuss the investment prospects of Bristol Myers Squibb, AbbVie, Johnson & Johnson, Pfizer, and Merck, covering their current performance, growth opportunities, and potential challenges.Stocks Mentioned in This EpisodeCompanyMarketRank™Current PriceDividend YieldP/E RatioABBVAbbVie4.8396 of 5 stars$199.57-0.5%3.29%69.30JNJJohnson & Johnson4.9921 of 5 stars$155.62-0.7%3.19%22.52BMYBristol-Myers Squibb4.7814 of 5 stars$54.16-1.0%4.43%-15.09PFEPfizer4.9935 of 5 stars$26.73-2.7%6.29%36.12MRKMerck & Co., Inc.5 of 5 stars$102.92+1.7%2.99%21.58 Compare These Stocks Add These Stocks to My Watchlist Chris Markoch, GuestMarketBeat Contributor, MarketBeatChris Markoch is a freelance financial copywriter with over five years of experience covering various aspects of the financial markets. You may find his writing a little different than other stock articles you’ve read. And that’s OK with him. Chris doesn’t have a traditional finance background. What he does bring to the table is a strong business and marketing background having worked for agencies that serviced Fortune 500 companies. With that in mind, he isn’t overly impressed with what companies say, and more focused on what they do. And because buyer behavior dictates so much of what happens with a stock, Chris always keeps the end consumer close in mind. Chris has been writing for MarketBeat since 2018.Thomas Hughes, GuestMarketBeat Contributor, MarketBeatThomas got his start with the markets while working as a Chef. In 2005 a chance invitation to attend the seminar “How To Buy And Sell Your Own Stocks” altered his worldview. Soon trading and stocks consumed his every waking moment to the point of excluding all else. Thomas now enjoys a much different lifestyle engaged in his true passion, uncovering great investments.Laycee Kluin, HostDigital Marketing Strategist, MarketBeatAs MarketBeat's Digital Marketing Strategist, Laycee helps with the marketing side of tasks including developing email campaigns, running the promotion of the MarketBeat products and exploring social media opportunities. She felt called to the Marketing industry because she enjoys collaborating with people and making connections. The University of Sioux Falls alum majored in Media Studies with minors in Communications and Spanish. Laycee brings a background in Financial Services Marketing.Previous VideoAll VideosNext Video Subscribe on YouTube Don't Miss a Video Subscribe to watch the latest stock market videos from MarketBeat. We empower investors to make better trading decisions by providing real-time financial data and objective market analysis. Subscribe on YouTube More From MarketBeatBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored7 Dividend Dynamos with a Yield of More Than 7%Despite signs of a slowing economy, investors continue to climb the wall of worry. And let's face it, many of ...MarketBeatTop "Sleeping Giant" Crypto In The Market NowTop "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your fi...Crypto 101 Media | Sponsored15 Healthcare Stocks that Analysts Love in a Post-Pandemic WorldThere are more than 200 healthcare companies traded on public markets. Given the sheer number of pharmaceutica...MarketBeatTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored7 Gold Stocks to Buy as the Metal Hits an All-Time HighEven its biggest critics can't deny that it's been a great year to own gold. More accurately, gold has had a g...MarketBeat Recent Videos Featured Articles and OffersSoundHound AI Will Advance By Triple Digits in 2025: Here’s WhyNovember 13, 2024View SoundHound AI Will Advance By Triple Digits in 2025: Here’s WhyTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersFrom Colonial Metals(Ad)View Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners3 "Made in America" Stocks to Benefit From the Trump PresidencyNovember 11, 2024View 3 "Made in America" Stocks to Benefit From the Trump Presidency2 Chip Stocks Benefitting from OpenAI’s Chip Strategy ExpansionNovember 11, 2024View 2 Chip Stocks Benefitting from OpenAI’s Chip Strategy ExpansionIs Tesla's Valuation a Bubble or Backed by Real Growth?November 12, 2024View Is Tesla's Valuation a Bubble or Backed by Real Growth?There is a little known company that is changing warfareFrom Reticulate(Ad)View There is a little known company that is changing warfare Search Headlines Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Hosted by MarketBeat StaffOctober 4, 2023 ShareLink copied to clipboard. Play video for Top 5 Pharmaceutical Stocks for Your WatchlistDetailsGuestsIn this video, we explore the top pharmaceutical stocks to watch, including industry giants and promising hidden gems. We discuss the investment prospects of Bristol Myers Squibb, AbbVie, Johnson & Johnson, Pfizer, and Merck, covering their current performance, growth opportunities, and potential challenges.Stocks Mentioned in This EpisodeCompanyMarketRank™Current PriceDividend YieldP/E RatioABBVAbbVie4.8396 of 5 stars$199.57-0.5%3.29%69.30JNJJohnson & Johnson4.9921 of 5 stars$155.62-0.7%3.19%22.52BMYBristol-Myers Squibb4.7814 of 5 stars$54.16-1.0%4.43%-15.09PFEPfizer4.9935 of 5 stars$26.73-2.7%6.29%36.12MRKMerck & Co., Inc.5 of 5 stars$102.92+1.7%2.99%21.58 Compare These Stocks Add These Stocks to My Watchlist Chris Markoch, GuestMarketBeat Contributor, MarketBeatChris Markoch is a freelance financial copywriter with over five years of experience covering various aspects of the financial markets. You may find his writing a little different than other stock articles you’ve read. And that’s OK with him. Chris doesn’t have a traditional finance background. What he does bring to the table is a strong business and marketing background having worked for agencies that serviced Fortune 500 companies. With that in mind, he isn’t overly impressed with what companies say, and more focused on what they do. And because buyer behavior dictates so much of what happens with a stock, Chris always keeps the end consumer close in mind. Chris has been writing for MarketBeat since 2018.Thomas Hughes, GuestMarketBeat Contributor, MarketBeatThomas got his start with the markets while working as a Chef. In 2005 a chance invitation to attend the seminar “How To Buy And Sell Your Own Stocks” altered his worldview. Soon trading and stocks consumed his every waking moment to the point of excluding all else. Thomas now enjoys a much different lifestyle engaged in his true passion, uncovering great investments.Laycee Kluin, HostDigital Marketing Strategist, MarketBeatAs MarketBeat's Digital Marketing Strategist, Laycee helps with the marketing side of tasks including developing email campaigns, running the promotion of the MarketBeat products and exploring social media opportunities. She felt called to the Marketing industry because she enjoys collaborating with people and making connections. The University of Sioux Falls alum majored in Media Studies with minors in Communications and Spanish. Laycee brings a background in Financial Services Marketing.Previous VideoAll VideosNext Video Subscribe on YouTube Don't Miss a Video Subscribe to watch the latest stock market videos from MarketBeat. We empower investors to make better trading decisions by providing real-time financial data and objective market analysis. Subscribe on YouTube More From MarketBeatBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored7 Dividend Dynamos with a Yield of More Than 7%Despite signs of a slowing economy, investors continue to climb the wall of worry. And let's face it, many of ...MarketBeatTop "Sleeping Giant" Crypto In The Market NowTop "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your fi...Crypto 101 Media | Sponsored15 Healthcare Stocks that Analysts Love in a Post-Pandemic WorldThere are more than 200 healthcare companies traded on public markets. Given the sheer number of pharmaceutica...MarketBeatTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored7 Gold Stocks to Buy as the Metal Hits an All-Time HighEven its biggest critics can't deny that it's been a great year to own gold. More accurately, gold has had a g...MarketBeat
